AZOR and Breastfeeding
It is not known if it is safe to breastfeed while taking AZOR (amlodipine and olmesartan). Breastfeeding women should talk to their healthcare providers about taking the medication because it may pass through breast milk to the nursing infant. In animal studies on olmesartan (one of the components of AZOR) and breastfeeding, the medication did pass through breast milk in low amounts. However, it is not known if the drug passes through breast milk in humans.
An Overview of AZOR and BreastfeedingIt is unknown if AZOR™ (amlodipine and olmesartan) passes through breast milk. As a result, it is also not known if AZOR is safe for women who are breastfeeding.
AZOR and Breastfeeding: What Does the Research Say?AZOR is a combination drug, containing olmesartan (Benicar®) and amlodipine (Norvasc®). No research has been done to see if amlodipine passes through breast milk. Olmesartan (the other component of AZOR) has been shown to pass through breast milk in low amounts in rats, but it is not known if the same is true for humans.
You may be wondering why no studies have been done to see if AZOR passes through breast milk in humans. In many situations, such studies would be considered unethical. These studies might put infants (who are unable to consent to these studies) at risk. In general, most information about breastfeeding and medications is obtained through cases outside of formal clinical studies.
Talking With Your Healthcare Provider About AZOR and BreastfeedingYou should talk with your healthcare provider about AZOR and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, you and your healthcare provider can make a shared decision about AZOR and breastfeeding in your particular situation.